Women’s health is finally stepping into the spotlight—conditions like menopause, endometriosis, and fertility are no longer taboo, but they’re still often spoken about in hushed tones. Momentum is building, with a surge in startups, growing media attention, and even Europe’s first femtech unicorn. But when it comes to funding, the gap remains stark. In 2023, just $1.1 billion of the $26.5 billion in healthcare venture capital went to women’s health—clear evidence that talk hasn’t yet translated into investment at scale. This session brings together bold voices from across the healthcare landscape to confront that gap. Why does women’s health still struggle to attract capital, despite its huge market potential and undeniable social impact? What will it take to shift the narrative—and the money? Expect a candid conversation on breaking down biases, changing investor mindsets, and building the commercial case for long-overdue innovation. It's time to turn the momentum into money, and ideas into impact. Join our fabulous speakers to explore how we move investing in women’s health from buzz to business.